Eli Lilly's AI Genetic Medicine Deal And What It Means For Valuation [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Eli Lilly (NYSE:LLY) has entered a large scale, multi program partnership with AI company Profluent to develop next generation genetic medicines. The collaboration focuses on using AI designed enzymes and recombinases to enable more precise and scalable DNA edits across multiple programs. The deal expands Lilly's push into digital biology and artificial intelligence in drug development, beyond recent M&A or product specific news. Eli Lilly comes into this agreement with Profluent as an established large cap pharma name, with its shares recently trading around $874.0. The stock has a 5 year return of about 388.1% and a 3 year return of about 121.1%. Over the past year, performance has been close to flat, with a 1 year return of about 0.5%. This partnership adds another pillar to Lilly's research toolkit and may influence how investors think about the breadth of its pipeline over time. For readers tracking NYSE:LLY, the move into AI driven genetic tools sits alongside existing
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Here's How Much Traders Expect Eli Lilly Stock To Move After Earnings [Yahoo! Finance]Yahoo! Finance
- Eli Lilly Stock Could Rise Sharply After Earnings [Seeking Alpha]Seeking Alpha
- Guggenheim Raises PT on Eli Lilly (LLY) Amid Several Acquisition Deals [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (LLY) Declined in Q1 Despite Strong Results [Yahoo! Finance]Yahoo! Finance
- Why WeightWatchers (WW) Shares Are Trading Lower Today [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 4/29/26 - Form PX14A6G
- 4/21/26 - Form 4
- 4/21/26 - Form 4
- LLY's page on the SEC website